TrialHuman vaccines & immunotherapeutics2017

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.

Maria Rosario Z Capeding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.